BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19396320)

  • 1. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction.
    Ahmadi F; Ali-Madadi A; Lessan-Pezeshki M; Khatami M; Mahdavi-Mazdeh M; Razeghi E; Maziar S; Seifi S; Abbasi M
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):54-8. PubMed ID: 18087123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
    Sáinz MM; Toro JC; Poblete HB; Perez LF; Nicovani VH; Carrera MG
    Transplant Proc; 2009; 41(6):2655-8. PubMed ID: 19715994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.
    Roodnat JI; van Gurp EA; Mulder PG; van Gelder T; de Rijke YB; de Herder WW; Kal-van Gestel JA; Pols HA; Ijzermans JN; Weimar W
    Transplantation; 2006 Aug; 82(3):362-7. PubMed ID: 16906034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
    Kanbay M; Isik B; Akcay A; Ozkara A; Karakurt F; Turgut F; Alkan R; Uz E; Bavbek N; Yigitoglu R; Covic A
    Am J Nephrol; 2007; 27(5):516-21. PubMed ID: 17703091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of post renal transplant hyperparathyroidism.
    Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of mineral metabolism markers on renal transplant outcomes.
    Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.
    Krüger B; Schnitzbauer AA; Böger CA; Hoffmann U; Banas B; Farkas S; Schlitt HJ; Obed A; Krämer BK
    Transplant Proc; 2006 Apr; 38(3):697-700. PubMed ID: 16647448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of delayed graft function in deceased donor renal transplants.
    Jushinskis J; Trushkov S; Bicans J; Suhorukov V; Shevelev V; Ziedina I; Rozental R
    Transplant Proc; 2009 Mar; 41(2):746-8. PubMed ID: 19328971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
    Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
    Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant inflammation: a risk factor for delayed graft function?
    Lauzurica R; Pastor MC; Bayés B; Hernandez JM; Bonet J; Doladé M; Navarro M; Romero R
    J Nephrol; 2008; 21(2):221-8. PubMed ID: 18446717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum phosphate predicts mortality in renal transplant recipients.
    Connolly GM; Cunningham R; McNamee PT; Young IS; Maxwell AP
    Transplantation; 2009 Apr; 87(7):1040-4. PubMed ID: 19352125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.